Jul 8, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2569047" data-attributes="member: 124445"><p>The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual ISH, allows for measurement of the number of copies of the HER2 gene in tumor tissue. The HER2 gene is located on chromosome 17 in human cells. An excessive amount of the protein produced by the gene is found in some types of cancer cells, including breast cancer cells... <a href="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/0CfeYLMBiUI" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/0CfeYLMBiUI/228534.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2569047, member: 124445"] The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual ISH, allows for measurement of the number of copies of the HER2 gene in tumor tissue. The HER2 gene is located on chromosome 17 in human cells. An excessive amount of the protein produced by the gene is found in some types of cancer cells, including breast cancer cells... [URL="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/0/da"][IMG]http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/1/da"][IMG]http://feedads.g.doubleclick.net/~a/pRG2CleiCP9IIPiOwVyWqIUHX7Y/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/0CfeYLMBiUI[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/0CfeYLMBiUI/228534.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top